FI944656A0 - Uudet kardioprotektiivset aineet - Google Patents

Uudet kardioprotektiivset aineet

Info

Publication number
FI944656A0
FI944656A0 FI944656A FI944656A FI944656A0 FI 944656 A0 FI944656 A0 FI 944656A0 FI 944656 A FI944656 A FI 944656A FI 944656 A FI944656 A FI 944656A FI 944656 A0 FI944656 A0 FI 944656A0
Authority
FI
Finland
Prior art keywords
cardioprotective agents
new
new cardioprotective
useful
tetraalkyl
Prior art date
Application number
FI944656A
Other languages
English (en)
Swedish (sv)
Other versions
FI944656A (fi
FI112658B (fi
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI944656A publication Critical patent/FI944656A/fi
Publication of FI944656A0 publication Critical patent/FI944656A0/fi
Application granted granted Critical
Publication of FI112658B publication Critical patent/FI112658B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Pyrane Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI944656A 1992-04-06 1994-10-05 Menetelmä uusien kardioprotektiivisten hydroksibentsopyraani-2-karboksyylihappojohdannaisten ja niiden laktonien valmistamiseksi FI112658B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92400957 1992-04-06
EP92400957 1992-04-06
PCT/US1993/002102 WO1993020058A1 (en) 1992-04-06 1993-03-08 Novel cardioprotective agents
US9302102 1993-03-08

Publications (3)

Publication Number Publication Date
FI944656A FI944656A (fi) 1994-10-05
FI944656A0 true FI944656A0 (fi) 1994-10-05
FI112658B FI112658B (fi) 2003-12-31

Family

ID=8211647

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944656A FI112658B (fi) 1992-04-06 1994-10-05 Menetelmä uusien kardioprotektiivisten hydroksibentsopyraani-2-karboksyylihappojohdannaisten ja niiden laktonien valmistamiseksi

Country Status (18)

Country Link
EP (1) EP0635010B1 (fi)
JP (1) JP3248183B2 (fi)
KR (1) KR100243820B1 (fi)
AT (1) ATE146175T1 (fi)
AU (1) AU667889B2 (fi)
CA (1) CA2132745C (fi)
DE (1) DE69306559T2 (fi)
DK (1) DK0635010T3 (fi)
ES (1) ES2098030T3 (fi)
FI (1) FI112658B (fi)
GR (1) GR3022471T3 (fi)
HU (1) HU217426B (fi)
IL (1) IL105320A (fi)
NO (1) NO307088B1 (fi)
NZ (1) NZ251131A (fi)
TW (1) TW232014B (fi)
WO (1) WO1993020058A1 (fi)
ZA (1) ZA932326B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
CN115073413B (zh) * 2022-05-17 2023-06-02 中山大学 一种苯并环醚类倍半萜类化合物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947473A (en) * 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs

Also Published As

Publication number Publication date
FI944656A (fi) 1994-10-05
ATE146175T1 (de) 1996-12-15
ES2098030T3 (es) 1997-04-16
DE69306559D1 (de) 1997-01-23
NO943727D0 (no) 1994-10-05
JPH07505392A (ja) 1995-06-15
FI112658B (fi) 2003-12-31
NO307088B1 (no) 2000-02-07
CA2132745C (en) 2000-03-21
AU667889B2 (en) 1996-04-18
KR950700896A (ko) 1995-02-20
IL105320A0 (en) 1993-08-18
CA2132745A1 (en) 1993-10-14
KR100243820B1 (ko) 2000-03-02
GR3022471T3 (en) 1997-05-31
ZA932326B (en) 1993-10-18
IL105320A (en) 1998-02-08
TW232014B (fi) 1994-10-11
NZ251131A (en) 1996-01-26
EP0635010B1 (en) 1996-12-11
DE69306559T2 (de) 1997-04-10
HUT68982A (en) 1995-08-28
DK0635010T3 (da) 1996-12-30
EP0635010A1 (en) 1995-01-25
NO943727L (no) 1994-12-05
HU9402863D0 (en) 1995-01-30
HU217426B (hu) 2000-01-28
JP3248183B2 (ja) 2002-01-21
WO1993020058A1 (en) 1993-10-14
AU3797293A (en) 1993-11-08

Similar Documents

Publication Publication Date Title
TR199801919T2 (xx) Rapamisin t�revlerinin damar hastal�klar� ve yabanc� doku naklinde kullan�m�.
DE69019774D1 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
ATE218320T1 (de) Kombinationen von vasoaktiven stoffen mit fettsäuren zur verhütung von haarausfall
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
DK0652208T3 (da) Phenylalkan(en)syrer
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
FI931204A0 (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
FI944656A0 (fi) Uudet kardioprotektiivset aineet
ES2110602T3 (es) Nuevos derivados de 2,3-dihidro-2,2,4,6,7-pentaalquil-5-benzofuranoles.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
NO890801L (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen

Legal Events

Date Code Title Description
MA Patent expired